A new procedure for preparation of polyethylene glycol-grafted magnetic iron oxide nanoparticles

被引：31
作者：
Khoee S. [1 ]
Kavand A. [1 ]
机构：
[1] Polymer Chemistry Department, School of Science, University of Tehran, PO Box 14155-6455, Tehran
来源：
Journal of Nanostructure in Chemistry | 2014年 / 4卷 / 3期
关键词：
Iron oxide nanoparticles; Polyethylene glycol; Sol–gel reaction; Surface modification;
D O I：
10.1007/s40097-014-0111-4
中图分类号：
学科分类号：
摘要：
Magnetic iron oxide nanoparticles (MNPs) have been widely explored for use in biomedical applications. In the present study, iron oxide nanoparticles were connected to methoxy poly(ethylene glycol) (mPEG) via a new method. The mPEG was acrylated at first and Michael reaction was carried out between acrylated mPEG and 3-aminopropyl triethoxysilane as a coupling agent. The chemical structures of modified mPEG were characterized by Fourier transform-infrared spectroscopy (FT-IR) and nuclear magnetic resonance. In the next step, iron oxide nanoparticle was coupled with the above-mentioned adduct. Preparation of magnetic nanoparticles with average particle size of 20–30 nm was proved by scanning electron microscopy. The structure of mPEG grafted on the surface of MNPs was confirmed by FT-IR spectroscopy and thermal gravimetric analysis. The synthesized nanoparticles have the potential to be used in different biomedical applications. © 2014, The Author(s).
引用
收藏
相关论文
共 27 条
  • [1] Weissleder R., Bogdanov A., Neuwelt E.A., Papisov M., Long circulating iron oxides for MR imaging, Adv. Drug Deliv. Rev., 16, pp. 321-334, (1995)
  • [2] Reimer P., Weissleder R., Development and experimental application of receptor-specific MR contrast media, Radiology, 36, pp. 153-163, (1996)
  • [3] Chouly C., Pouliquen D., Lucet L., Jeune J.J., Jallet P., Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution, J. Microencapsul., 13, pp. 245-255, (1996)
  • [4] Gupta P.K., Hung C.T., Magnetically controlled targeted micro-carrier systems, Life Sci., 44, pp. 175-186, (1989)
  • [5] Kumar C.S.S.R., Mohammad F., Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery, Adv. Drug Deliv. Rev., 63, pp. 789-808, (2011)
  • [6] Xie J., Lee S., Chen X.Y., Nanoparticle-based theranostic agents, Adv. Drug Deliv. Rev., 62, pp. 1064-1079, (2011)
  • [7] Berry C.C., Wells S., Charles S., Aitchison G., Curtis A.S., Cell response to dextran-derivatised iron oxide nanoparticles post internalisation, Biomaterials, 25, pp. 5405-5413, (2004)
  • [8] Zhang Y., Kohler N., Zhang M., Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake, Biomaterials, 23, pp. 1553-1561, (2002)
  • [9] D'Souza A.J., Schowen R.L., Topp E.M.J., Polyvinylpyrrolidone–drug conjugate: synthesis and release mechanism, Control. Release, 94, pp. 91-100, (2004)
  • [10] Bae K.H., Park M., Do M.J., Lee N., Ryu J.H., Kim G.W., Kim C.G., Park T.G., Hyeon T., Chitosan oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia, ACS Nano, 6, pp. 5266-5273, (2012)
123